Ausgabe 2/2006
Inhalt (15 Artikel)
Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1
Chiachen Chen, Yuan-Ching Chang, Chien-Liang Liu, King-Jen Chang, Ing-Cherng Guo
AFPep: an anti-breast cancer peptide that is orally active
James A. Bennett, Lori DeFreest, Ikenna Anaka, Hamid Saadati, Sujata Balulad, Herbert I. Jacobson, Thomas T. Andersen
Population-based mammography screening results in substantial savings in treatment costs for fatal breast cancer
Lea Kauhava, Pirjo Immonen-Räihä, Ilmo Parvinen, Kaija Holli, Pauliina Kronqvist, Liisa Pylkkänen, Hans Helenius, Anne Kaljonen, Osmo Räsänen, Pekka J. Klemi
Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer
Lukas A. Hefler, Christoph Grimm, Tilmann Lantzsch, Dieter Lampe, Heinz Koelbl, Antje Lebrecht, Georg Heinze, Clemens Tempfer, Alexander Reinthaller, Robert Zeillinger
Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women
Roni T. Falk, Louise A. Brinton, M. Patricia Madigan, Nancy Potischman, Susan R. Sturgeon, Kathleen E. Malone, Janet R. Daling
Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer
Harriet Johansson, Bernardo Bonanni, Frederique Mariette, Massimiliano Cazzaniga, Laura Baglietto, Aliana Guerrieri-Gonzaga, Maria Teresa Sandri, Alberto Luini, Giuseppe Pelosi, Andrea Decensi
No nodal cutoff in node-positive breast cancer women treated with mastectomy
V Vinh-Hung, G Storme
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients
Erich F. Solomayer, Sven Becker, Graziella Pergola-Becker, Robert Bachmann, Bernhard Krämer, Ulrich Vogel, Hans Neubauer, Diethelm Wallwiener, Jens Huober, Tanja N. Fehm
Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA
Patrizia Dell’Orto, Maria Olivia Biasi, Barbara Del Curto, Stefano Zurrida, Viviana Galimberti, Giuseppe Viale
Identification of BAF57 mutations in human breast cancer cell lines
Evangelos Kiskinis, Juana M. García-Pedrero, M. Angeles Villaronga, Malcolm G. Parker, Borja Belandia
Fruits, vegetables, and micronutrient intake in relation to breast cancer survival
Brian N. Fink, Mia M. Gaudet, Julie A. Britton, Page E. Abrahamson, Susan L. Teitelbaum, Judith Jacobson, Paula Bell, Joyce A. Thomas, Geoffrey C. Kabat, Alfred I. Neugut, Marilie D. Gammon
XPD Common Variants and their Association with Melanoma and Breast Cancer Risk
T. Dębniak, R.J. Scott, T. Huzarski, T. Byrski, B. Masojć, T. van de Wetering, P. Serrano-Fernandez, B. Górski, C. Cybulski, J. Gronwald, B. Dębniak, R. Maleszka, J. Kładny, A. Bieniek, L. Nagay, O. Haus, E. Grzybowska, P. Wandzel, S. Niepsuj, S.A. Narod, and J. Lubinski
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52
James N. Ingle, Vera J. Suman, James A. Mailliard, John W. Kugler, James E. Krook, John C. Michalak, Thomas M. Pisansky, Lester E. Wold, John H. Donohue, Matthew P. Goetz, Edith A. Perez
High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer
Paul N. Span, Vivianne C.G. Tjan-Heijnen, Peggy Manders, Doorlene van Tienoven, Jeffrey Lehr, Fred C.G.J. Sweep
Expression of “Spot 14” (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker
Wendy A. Wells, Gary N. Schwartz, Peter M. Morganelli, Bernard F. Cole, Jennifer J. Gibson, William B. Kinlaw